Recurrent Episodes with Serous Retinal Detachment and Anterior Uveitis in a Patient Using Nivolumab (Anti -PD-1 Antibody) Therapy: A case report and literature review
SEMINARS IN OPHTHALMOLOGY, cilt.36, sa.8, ss.794-799, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 36 Sayı: 8
- Basım Tarihi: 2021
- Doi Numarası: 10.1080/08820538.2021.1906916
- Dergi Adı: SEMINARS IN OPHTHALMOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
- Sayfa Sayıları: ss.794-799
- Anahtar Kelimeler: Metastatic malignant melanoma, nivolumab, serous retinal detachment, anterior uveitis, anti-PD-1 antibody
- Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet
Özet
Aim: Nivolumab is an immune checkpoint inhibitor that has recently been widely used for metastatic malignant melanoma. We report a case who developed multiple different ocular immune-related side effects (iRAEs) related to nivolumab.